beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.

Drugs of today (Barcelona, Spain : 1998)

Volumn 45, Issue 4, 2009, Pages 293-304

  Adlard, Paul A ^a   James, Simon A ^a   Bush, Ashley I ^a   Masters, Colin L ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL; CLINICAL TRIAL; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; HUMANS;

EID: 69849108778     PISSN: 16993993     EISSN: None     Source Type: Journal    
DOI: 10.1358/dot.2009.045.004.1353853     Document Type: Review

References (101)